Amalgamated Bank’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$721K Sell
23,384
-830
-3% -$20.5K 0.01% 1243
2026
Q1
$523K Sell
24,214
-387
-2% -$8.36K ﹤0.01% 1296
2025
Q4
$586K Buy
24,601
+5,068
+26% +$103K ﹤0.01% 1269
2025
Q3
$266K Buy
19,533
+736
+4% +$7.65K ﹤0.01% 1497
2025
Q2
$153K Hold
18,797
﹤0.01% 1615
2025
Q1
$148K Buy
18,797
+2,922
+18% +$33.9K ﹤0.01% 1601
2024
Q4
$236K Sell
15,875
-144
-0.9% -$2.35K ﹤0.01% 1537
2024
Q3
$245K Sell
16,019
-165
-1% -$2.6K ﹤0.01% 1526
2024
Q2
$246K Sell
16,184
-1,157
-7% -$18.7K ﹤0.01% 1522
2024
Q1
$327K Sell
17,341
-3,686
-18% -$63.7K ﹤0.01% 1456
2023
Q4
$402K Sell
21,027
-963
-4% -$15.4K ﹤0.01% 1524
2023
Q3
$395K Hold
21,990
﹤0.01% 1525
2023
Q2
$447K Buy
21,990
+272
+1% +$5.18K ﹤0.01% 1488
2023
Q1
$396K Sell
21,718
-1,876
-8% -$35.9K ﹤0.01% 1522
2022
Q4
$488K Buy
23,594
+157
+0.7% +$4.32K ﹤0.01% 1475
2022
Q3
$613K Buy
23,437
+1,881
+9% +$49.7K 0.01% 1334
2022
Q2
$546K Buy
21,556
+16,147
+299% +$395K 0.01% 1424
2022
Q1
$171K Sell
5,409
-429
-7% -$14.4K ﹤0.01% 1998
2021
Q4
$236K Sell
5,838
-87
-1% -$3.38K ﹤0.01% 1914
2021
Q3
$207K Buy
+5,925
New +$184K ﹤0.01% 1983

Other funds holding RCUS

Amalgamated Bank's RCUS Position: Q2 2026 in Review

Amalgamated Bank reduced its Arcus Biosciences (RCUS) stake by 3.4% in Q2 2026, selling an estimated $20.5K and leaving 23,384 shares worth $721K. The position accounts for 0.01% of the portfolio, ranked #1243.

Amalgamated Bank first reported a position in RCUS in Q3 2021 and has held it in 20 quarters since. 75 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Amalgamated Bank held 23,384 shares of Arcus Biosciences worth $721K as of Q2 2026.
  • Amalgamated Bank sold 830 Arcus Biosciences shares in Q2 2026, an estimated $20.5K.
  • Arcus Biosciences made up 0.01% of Amalgamated Bank's portfolio in Q2 2026, its #1243 holding.
  • Amalgamated Bank first reported a position in Arcus Biosciences in Q3 2021 and has held it in 20 quarters since.
  • 75 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.